Modulation of interhemispheric functional coordination in electroconvulsive therapy for depression

Translational Psychiatry

Volumn 4, Issue 9, 2014, Pages

  Wei, Q ^a   Tian, Y ^a   Yu, Y ^a   Zhang, F ^a   Hu, X ^a,b   Dong, Y ^b   Chen, Y ^b   Hu, P ^a   Wang, K ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SHANDONG MENTAL HEALTH CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGULAR GYRUS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COORDINATION; DEPRESSION; EDUCATIONAL STATUS; ELECTROCONVULSIVE THERAPY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAMILTON DEPRESSION RATING SCALE; HUMAN; INTERHEMISPHERIC FUNCTIONAL COORDINATION; MALE; MIDDLE FRONTAL GYRUS; RIGHT HEMISPHERE; SUPERIOR FRONTAL GYRUS; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER; IMAGE PROCESSING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84927798274     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.101     Document Type: Article

References (92)

1. Baio J. Prevalence of autism spectrum disorders-Autism and developmental disabilities monitoring network, 14 Sites, United States, 2008. Centers Dis Control Prev MMWR Surveill Summ 2012; 61: 1-19.
2. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999; 65: 931.
3. Geschwind DH. Advances in autism. Annu Rev Med 2009; 60: 367-380.
4. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466: 368-372.
5. Kalscheuer VM, FitzPatrick D, Tommerup N, Bugge M, Niebuhr E, Neumann LM et al. Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation. Hum Genet 2007; 121: 501-509.
6. Bakkaloglu B, Roak BJO, Louvi A, Gupta AR, Abelson JF, Morgan TM et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-Like 2 in autism spectrum disorders. Am J Hum Genet 2008; 82: 165-173.
7. Huang X-L, Zou YS, Maher T a, Newton S, Milunsky JM. A de novo balanced translocation breakpoint truncating the autism susceptibility candidate 2 (AUTS2) gene in a patient with autism. Am J Med Genet A 2010; 152A: 2112-2114.
8. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S et al. Autism genomewide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459: 569-573.
9. Ben-David E, Granot-Hershkovitz E, Monderer-Rothkoff G, Lerer E, Levi S, Yaari M et al. Identification of a functional rare variant in autism using genome-wide screen for monoallelic expression. Hum Mol Genet 2011; 20: 3632-3641.
10. Girirajan S, Brkanac Z, Coe BP, Baker C, Vives L, Vu TH et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011; 7: e1002334.
11. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012; 149: 525-537.
12. Nagamani SCS, Erez A, Ben-Zeev B, Frydman M, Winter S, Zeller R et al. Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders. Eur J Hum Genet 2013; 21: 1-4.
13. Beunders G, Voorhoeve E, Golzio C, Pardo LM, Rosenfeld J a, Talkowski ME et al. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am J Hum Genet 2013; 92: 210-220.
14. Girirajan S, Johnson RL, Tassone F, Balciuniene J, Katiyar N, Fox K et al. Global increases in both common and rare copy number load associated with autism. Hum Mol Genet 2013; 22: 2870-2880.
15. Cusco I, Medrano A, Gener B. Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder. Hum Mol Genet 2009; 18: 1795-1804.
16. Tropeano M, Ahn JW, Dobson RJB, Breen G, Rucker J, Dixit A et al. Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders. PLoS ONE 2013; 8: e61365.
17. Jolley A, Corbett M, McGregor L, Waters W, Brown S, Nicholl J et al. De novo intragenic deletion of the autism susceptibility candidate 2 (AUTS2) gene in a patient with developmental delay: a case report and literature review. Am J Med Genet A 2013; 2: 1-5.
18. Mefford HC, Muhle H, Ostertag P, von Spiczak S, Buysse K, Baker C et al. Genomewide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010; 6: e1000962.
19. Hamshere ML, Green EK, Jones IR, Jones L, Moskvina V, Kirov G et al. Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br J Psychiatry 2009; 195: 23-29.
20. Hattori E, Toyota T, Ishitsuka Y, Iwayama Y, Yamada K, Ujike H et al. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 1110-1117.
21. Lee H, Woo H, Greenwood T. A genome-wide association study of seasonal pattern mania identifies NF1A as a possible susceptibility gene for bipolar disorder. J Affect Disord 2012; 145: 200-207.
22. Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010; 15: 637-646.
23. Luciano M, Hansell N, Lahti J. Whole genome association scan for genetic polymorphisms influencing information processing speed. Biol Psychol 2011; 86: 193-202.
24. Chojnicka I, Gajos K, Strawa K, Broda G, Fudalej S, Fudalej M et al. Possible association between suicide committed under influence of ethanol and a variant in the AUTS2 gene. PLoS ONE 2013; 8: e57199.
25. Schumann G, Coin LJ, Lourdusamy A, Charoen P, Berger KH, Stacey D et al. Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci USA 2011; 108: 7119-7124.
26. Pollard KS, Salama SR, Lambert N, Lambot M-A, Coppens S, Pedersen JS et al. An RNA gene expressed during cortical development evolved rapidly in humans. Nature 2006; 443: 167-172.
27. Prabhakar S, Noonan JP, Paabo S, Rubin EM. Accelerated evolution of conserved noncoding sequences in humans. Science 2006; 314: 786.
28. Green RE, Krause J, Briggs AW, Maricic T, Stenzel U, Kircher M et al. A draft sequence of the Neandertal genome. Science 2010; 328: 710-722.
29. Bedogni F, Hodge RD, Nelson BR, Frederick E a, Shiba N, Daza Ra et al. Autism susceptibility candidate 2 (Auts2) encodes a nuclear protein expressed in developing brain regions implicated in autism neuropathology. Gene Exp Patterns 2010; 10: 9-15.
30. Oksenberg N, Stevison L, Wall JD, Ahituv N. Function and regulation of AUTS2, a gene implicated in autism and human evolution. PLoS Genet 2013; 9: e1003221.
31. Sultana R, Yu C-E, Yu J, Munson J, Chen D, Hua W et al. Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics 2002; 80: 129-134.
32. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246-250.
33. Bedogni F, Hodge RD, Elsen GE, Nelson BR, Daza R a M, Beyer RP et al. Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex. Proc Natl Acad Sci USA 2010; 107: 13129-13134.
34. Fatemi SH, Snow A V, Stary JM, Araghi-Niknam M, Reutiman TJ, Lee S et al. Reelin signaling is impaired in autism. Biol Psychiatry 2005; 57: 777-787.
35. Srinivasan K, Leone DP, Bateson RK, Dobreva G, Kohwi Y, Kohwi-Shigematsu T et al. A network of genetic repression and derepression specifies projection fates in the developing neocortex. Proc Natl Acad Sci USA 2012; 109: 19071-19078.
36. Ben-Shachar S, Chahrour M, Thaller C, Shaw C a, Zoghbi HY. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 2009; 18: 2431-2442.
37. Young EJ, Lipina T, Tam E, Mandel a, Clapcote SJ, Bechard a R et al. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-Targeted mice. Genes Brain Behav 2008; 7: 224-234.
38. O'Leary J, Osborne LR. Global analysis of gene expression in the developing brain of Gtf2ird1 knockout mice. PLoS ONE 2011; 6: e23868.
39. Sedaghat Y, Mazur C, Sabripour M, Hung G, Monia BP. Genomic analysis of wig-1 pathways. PLoS ONE 2012; 7: e29429.
40. Oksenberg N, Ahituv N. The role of AUTS2 in neurodevelopment and human evolution. Trends Genet 2013; 29: 1-9.
41. Molnar C, de Celis JF. Tay Bridge is a negative regulator of EGFR signalling and interacts with Erk and Mkp3 in the Drosophila melanogaster wing. PLoS Genet 2013; 9: e1003982.
42. Hashimoto-Torii K, Torii M, Sarkisian MR, Bartley CM, Shen J, Radtke F et al. Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. Neuron 2008; 60: 273-284.
43. Wang G-S, Hong C-J, Yen T-Y, Huang H-Y, Ou Y, Huang T-N et al. Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron 2004; 42: 113-128.
44. William D a, Saitta B, Gibson JD, Traas J, Markov V, Gonzalez DM et al. Identification of oscillatory genes in somitogenesis from functional genomic analysis of a human mesenchymal stem cell model. Dev Biol 2007; 305: 172-186.
45. Dequeant M-L, Glynn E, Gaudenz K, Wahl M, Chen J, Mushegian A et al. A complex oscillating network of signaling genes underlies the mouse segmentation clock. Science 2006; 314: 1595-1598.
46. Gao Z, Zhang J, Bonasio R, Strino F, Sawai A, Parisi F et al. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol Cell 2012; 45: 344-356.
47. Cheng Y, Quinn JF, Weiss LA. An eQTL mapping approach reveals that rare variants in the SEMA5A regulatory network impact autism risk. Hum Mol Genet 2013; 22: 1-13.
48. Tian W, Skolnick J. How well is enzyme function conserved as a function of pairwise sequence identity? J Mol Biol 2003; 333: 863-882.
49. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10: R25.
50. Zhang Y, Liu T, Meyer C a, Eeckhoute J, Johnson DS, Bernstein BE et al. Modelbased analysis of ChIP-Seq (MACS). Genome Biol 2008; 9: R137.
51. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25: 1105-1111.
52. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14: R36.
53. Anders S, McCarthy DJ, Chen Y, Okoniewski M, Smyth GK, Huber W et al. Countbased differential expression analysis of RNA sequencing data using R and Bioconductor. Nat Protoc 2013; 8: 1765-1786.
54. Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S et al. A map of the cis-regulatory sequences in the mouse genome. Nature 2012; 488: 116-120.
55. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010; 26: 841-842.
56. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28: 495-501.
57. Bailey TL, Gribskov M. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. In: Proceedings of the Second International Conference on Intelligent Systems for Molecular Biology. Menlo Park, California 1994 p 2: 28-36.
58. Kulakovskiy I V, Boeva V a, Favorov a V, Makeev VJ. Deep and wide digging for binding motifs in ChIP-Seq data. Bioinformatics 2010; 26: 2622-2623.
59. Machanick P, Bailey TL. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 2011; 27: 1696-1697.
60. Buske F a, Boden M, Bauer DC, Bailey TL. Assigning roles to DNA regulatory motifs using comparative genomics. Bioinformatics 2010; 26: 860-866.
61. Abrahams BS, Arking DE, Campbell DB, Mefford HC, Morrow EM, Weiss L a et al. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs). Mol Autism 2013; 4: 36.
62. Li Q, Ritter D, Yang N, Dong Z, Li H, Chuang JH et al. A systematic approach to identify functional motifs within vertebrate developmental enhancers. Dev Biol 2010; 337: 484-495.
63. Westerfield M. The Zebrafish Book. 5th edn, University of Oregon Press: Eugene, Oregon, 2007.
64. Nusslein-Volhard C, RD. Zebrafish. Oxford University Press: Oxford, 2002.
65. Kawakami K. Transposon tools and methods in zebrafish. Dev Dyn 2005; 234: 244-254.
66. Finlay B, Darlington R. Linked regularities in the development and evolution of mammalian brains. Science 1995; 268: 1578-1584.
67. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005; 15: 1034-1050.
68. Egaas B, Courchesne E, Saitoh O. Reduced size of corpus callosum in autism. Arch Neurol 1995; 52: 794-801.
69. Lainhart J, Lange N. Increased neuron number and head size in autism. JAMA J Am Med 2011; 306: 2031-2032.
70. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ et al. Neuron number and size in prefrontal cortex of children with autism. JAMA 2011; 306: 2001-2010.
71. Chung S, Hedlund E, Hwang M, Kim DW, Shin B-S, Hwang D-Y et al. The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol Cell Neurosci 2005; 28: 241-252.
72. Philippi A, Tores F, Carayol J, Rousseau F, Letexier M, Roschmann E et al. Association of autism with polymorphisms in the paired-like homeodomain transcription factor 1 (PITX1) on chromosome 5q31: a candidate gene analysis. BMC Med Genet 2007; 8: 74.
73. Slattery C, Ryan MP, McMorrow T. E2A proteins: regulators of cell phenotype in normal physiology and disease. Int J Biochem Cell Biol 2008; 40: 1431-1436.
74. Massari M, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000; 20: 429-440.
75. Gray P a, Fu H, Luo P, Zhao Q, Yu J, Ferrari A et al. Mouse brain organization revealed through direct genome-scale TF expression analysis. Science 2004; 306: 2255-2257.
76. Kelliher M a, Seldin DC, Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J 1996; 15: 5160-5166.
77. Barber KE, Harrison CJ, Broadfield ZJ, Stewart ARM, Wright SL, Martineau M et al. Molecular Cytogenetic characterization of TCF3 acute lymphoblastic leukemia. Genes Chromosom Cancer 2007; 46: 478-486.
78. Xie Q, Hao Y, Tao L, Peng S, Rao C, Chen H et al. Lysine methylation of FOXO3 regulates oxidative stress-induced neuronal cell death. EMBO Rep 2012; 13: 371-377.
79. Kondrashov N, Pusic A, Stumpf CR, Shimizu K, Hsieh AC, Xue S et al. Ribosomemediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 2011; 145: 383-397.
80. Wen R-T, Zhang M, Qin W-J, Liu Q, Wang W-P, Lawrence AJ et al. The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. Alcohol Clin Exp Res 2012; 36: 2157-2167.
81. Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD. Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 2009; 8: 64-69.
82. Xi B, Chen J, Yang L, Wang W, Fu M, Wang C. GABBR1 gene polymorphism (G1465A) is associated with temporal lobe epilepsy. Epilepsy Res 2011; 96: 58-63.
83. Enoch M-A, Zhou Z, Kimura M, Mash DC, Yuan Q, Goldman D. GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naive P and NP rats. PLoS ONE 2012; 7: e29369.
84. Maraganore DM, Lesnick TG, Elbaz A, Chartier-Harlin M-C, Gasser T, Kruger R et al. UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 2004; 55: 512-521.
85. Watanabe E, Aono S, Matsui F, Yamada Y, Naruse I, Oohira a. Distribution of a brain-specific proteoglycan, neurocan, and the corresponding mRNA during the formation of barrels in the rat somatosensory cortex. Eur J Neurosci 1995; 7: 547-554.
86. Cichon S, Muhleisen TW, Degenhardt F a, Mattheisen M, Miro X, Strohmaier J et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011; 88: 372-381.
87. Muhleisen TW, Mattheisen M, Strohmaier J, Degenhardt F, Priebe L, Schultz CC et al. Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res 2012; 138: 69-73.
88. Missler M, Sudhof T. Neurexins: three genes and 1001 products. Trends Genet 1998; 14: 20-26.
89. Ching MSL, Shen Y, Tan W-H, Jeste SS, Morrow EM, Chen X et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 937-947.
90. Diez-Roux G, Banfi S, Sultan M, Geffers L, Anand S, Rozado D et al. A highresolution anatomical atlas of the transcriptome in the mouse embryo. PLoS Biol 2011; 9: e1000582.
91. Carayol J, Sacco R, Tores F, Rousseau F, Lewin P, Hager J et al. Converging evidence for an association of ATP2B2 allelic variants with autism in male subjects. Biol Psychiatry 2011; 70: 880-887.
92. Yang W, Liu J, Zheng F, Jia M, Zhao L, Lu T et al. The evidence for association of ATP2B2 polymorphisms with autism in Chinese Han population. PLoS ONE 2013; 8: e61021.